Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2006, p. 5908-5920, Vol. 26, No. 15
0270-7306/06/$08.00+0 doi:10.1128/MCB.00269-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030,1 Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030,2 Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892,3 Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 208924
Received 13 February 2006/ Returned for modification 13 March 2006/ Accepted 15 May 2006
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
CGD patients suffer from frequent bacterial and fungal infections and inflammatory granulomas in the lungs, liver, skin, lymph nodes, and lining of the gastrointestinal and genitourinary tracts (34); loss of phagocytic oxidative burst activity due to mutations in genes encoding the NADPH oxidase subunits is the cause of these symptoms. gp91phox (40) and p47phox (22) mutant mice have been generated and used as models for the most common mutations that cause CGD. These mutant mouse lines, which lack their respective gene products due to targeted homologous recombinant gene disruption, have been utilized to understand the molecular mechanisms underlying CGD (22, 40).
NADPH oxidase has been studied primarily for its role in the phagocyte oxidative burst in the immune system (43); however, its regulation and expression pattern suggest that it may be an important source of superoxide in the brain (9, 46, 54). Interestingly, some CGD patients also suffer from cognitive dysfunction (37), indicating that the lack of a fully functional NADPH oxidase impairs higher-order brain function. NADPH oxidase function in the nervous system has been well studied in microglia (9), and a role for NADPH oxidase in astrocyte function has been described (1). Moreover, it has been demonstrated that NADPH oxidase is expressed in neurons (51, 54) and localized at synapses (51). These findings indicate that NADPH oxidase may be a source of superoxide that is required for normal brain function.
Superoxide is known to be required for hippocampal synaptic plasticity, specifically long-term potentiation (LTP) (25-27, 52, 53), as well as hippocampus-dependent memory (27, 52, 53). However, the source of superoxide required for LTP and memory formation has yet to be determined. We previously have shown that superoxide is required for N-methyl-D-aspartate (NMDA) receptor-dependent activation of extracellular signal-regulated kinase (ERK) in the hippocampus (24) and that a likely source of superoxide required for ERK activation is NADPH oxidase (24). Thus, we hypothesized that NADPH oxidase could be a source of superoxide that is required for hippocampal LTP and memory. In order to test this hypothesis directly, we examined LTP in hippocampal slices treated with two structurally and functionally different NADPH oxidase inhibitors. We also examined LTP in hippocampal slices prepared from either gp91phox or p47phox mutant mice. In addition, we tested the ability of the NADPH oxidase mutant mice to perform hippocampus-dependent learning and memory tasks. Our data indicate that the loss of a functional NADPH oxidase results in deficient LTP and mild hippocampus-dependent memory impairments. Our data are the first to show a direct role of NADPH oxidase involvement in hippocampal synaptic plasticity and memory formation. Overall, these findings are consistent with the idea that superoxide produced by NADPH oxidase is required for normal hippocampal synaptic plasticity and memory and may explain why some CGD patients exhibit cognitive dysfunction.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Electrophysiology. Hippocampi from 2- to 3-month-old wild-type, gp91phox KO, and p47phox KO mice were removed, and 400-µm slices were prepared using a tissue chopper as previously described (24). The slices were perfused for 1 to 2 h with oxygenated artificial cerebrospinal fluid (ACSF; in mM: 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 D-glucose, 2 CaCl2, and 1 MgCl2) in an interface tissue slice chamber at 30°C. A bipolar stimulating electrode was placed to stimulate the Schaffer collaterals emanating from CA3 pyramidal neurons, and the recording electrode was placed in the stratum radiatum in area CA1.
Input/output. In order to determine the response range for each hippocampal slice, the stimulus range was divided into 10 arbitrary units. The slices were stimulated at each level, and the field excitatory postsynaptic potential (fEPSP) was recorded. Within each fEPSP waveform, the fiber volley was used to determine the input value (amplitude of the fiber volley). The range of input values and their respective output values (measured as the fEPSP slope) were plotted as a means to characterize basal synaptic transmission in mutant mice and wild-type littermates across all experiments performed. At the start of each experiment, the maximal fEPSP response was determined, as was the stimulation intensity that elicited 30 to 50% of the maximal fEPSP response. No differences were found between wild-type littermates of the gp91phox KO and wild-type littermates of the p47phox KO mice and, thus, these animals were grouped for further analyses.
Baseline responses. Baseline responses were collected using the stimulation intensity which elicited 30 to 50% of the maximal fEPSP response as determined by the input-output relationship described above. Data points were collected every 2 minutes as the average response of six fEPSPs collected every 20 seconds.
Induction of LTP. Following 20 min of baseline recording, a single high-frequency stimulus (HFS) at maximal intensity (100 Hz for 1 s) was delivered. Following the HFS, recordings resumed for 45 min. Long-lasting LTP (L-LTP) was elicited using a previously described L-LTP induction protocol (3); briefly, four trains of HFS (100 Hz for 1 s) spaced 5 min apart were delivered following a 20-min baseline. Potentiated responses were then tracked for 3 h.
Pharmacology. Baseline responses were recorded for 20 min before the addition of either diphenylene iodonium (DPI) or apocynin. Then, either vehicle, 10 µM DPI, or 100 µM apocynin was applied for 20 min while the recordings continued. For LTP experiments, a single HFS (as described above) was delivered 10 min after the application of the pharmacological agent. Following the 20-min application, the pharmacological agent was removed and the recordings continued for the indicated amount of time.
PTP. Posttetanic potentiation (PTP) was induced with a single train of HFS (100 Hz for 1 second) in the presence of 2-amino-5-phosphonovaleric acid (APV; 100 µM) in ACSF. fEPSPs were recorded every 20 seconds for 2 minutes prior to the HFS and every second for 15 seconds immediately post-HFS. After the initial 15 seconds post-HFS, fEPSPs were recorded for 2 min, 5 min post-HFS. Single fEPSP traces collected at each time point were used to measure the slope of the fEPSP, which was plotted as the mean ± the standard error of the mean over multiple trials over the time course of the experiment. PTP values in the wild-type littermates for each of the mutant mice were not significantly different from each other and thus were grouped for further analysis and presentation.
PPF. Paired-pulse facilitation (PPF), a presynaptic facilitation, was induced with two stimuli of equal intensity (same as baseline intensity) presented in rapid succession at variable interpulse intervals ranging from 10 ms to 400 ms. PPF was measured by examining the ratio of the fEPSP slope of stimulus 2 to that of stimulus 1. PPF values in the wild-type littermates from each of the mutant mice were not significantly different from each other and thus were grouped for data presentation.
Isolation of NMDA receptor-mediated fEPSPs.
Baseline fEPSPs were collected as described above. Subsequently, ACSF containing 0 mM MgCl2 and 4 mM CaCl2 was applied to elicit mixed AMPA (
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) and NMDA receptor-mediated fEPSPs. CNQX (6-cyano-2,3-dihydroxy-7-nitro-quinoxaline) at 20 µM then was applied to isolate NMDA receptor-mediated fEPSPs. Confirmation that the remaining fEPSP was mediated by NMDA receptors was obtained by applying 100 µM APV, which completely abolished any remaining fEPSP response.
Synaptic fatigue analysis. Baseline fEPSPs were collected as described above. APV at 100 µM was applied to the slices for at least 20 min prior to the delivery of a 10-Hz stimulation protocol that lasted 3 seconds. The resultant fEPSPs were recorded during the stimulation protocol and analyzed.
Conditioned fear. Associative memory was assessed using the conditioned fear paradigm. The training sessions for contextual and cued conditioned fear consisted of a 2-min exploratory period followed by two conditioned stimulus-unconditioned stimulus pairings (a 30-s, 90-db white noise tone and a 2-s, 0.9-mA foot shock at the end of the tone) separated by 1 minute. Contextual tests were performed in the training chamber 24 h later. Cue testing was performed in a distinct chamber 25 h following training. Baseline freezing behavior was monitored for 3 minutes prior to the presentation of the testing tone (3-min, 90-db white noise tone). Freezing behavior was monitored throughout the testing phases to compare fearful responses to the contextual and cued conditional stimuli across wild-type and mutant mice.
MWM. Spatial learning and memory were tested using the Morris water maze (MWM). During the training phase, mice were given four trials each day (60-second maximum duration per trial, with an intertrial interval of at least 20 min) for four consecutive days followed by a single probe trial (testing trial) on the fifth day. The training and probe trial regimen was repeated once for a total of 10 days of experimentation (4 days of training, 1 day of testing, 4 days of training, and 1 day of testing). The latency to find the platform was recorded for each training day. For each of the probe trials, the platform was removed and the number of times the mice crossed over where the platform had been was recorded during a 1-minute trial, as was the time spent in each of the four quadrants in the pool. All data were collected digitally using a charge-coupled device camera placed directly over the pool and coupled with video tracking software (Noldus EthoVision System).
Rotating rod. Motor coordination, balance, and memory were tested using an accelerating rotating rod (Ugo Basile Biological Research Apparatus, Italy) (38). Mice were tested repeatedly on two consecutive days, four trials per day, and the time the mice were able to remain balanced on the rotating rod was recorded.
Open field analysis. Locomotor activity was assessed as described previously (38). Data were collected in 2-minute intervals over a 30-minute test session using Versamax software (Accuscan Inc., Columbus, OH) for data collection and analysis. Total distance (in cm) traveled during the assay was measured. Center distance was divided by the total distance to obtain a center distance/total distance ratio. Vertical activity (rearing, measured by the number of photobeam interruptions) and horizontal activity (locomotor activity, measured by the number of photobeam interruptions) also were measured.
Nissl staining. Mice were perfused with 4% paraformaldehyde in phosphate-buffered solution, and brains were prepared for cryostat sectioning as previously described (12). Twenty-micrometer sections were collected using a cryostat and mounted on plus-superfrost glass slides. Sections then were prepared, stained with cresyl violet, and mounted. Images were collected using an inverted light microscope equipped with a digital camera connected to a computer. Images then were cropped and rotated for presentation using Adobe Photoshop.
Data analysis. The results for all experiments are presented as means ± the standard errors of the means. For comparisons between two groups, a two-tailed Student's t test was used. All time course experiments involving multiple comparisons were analyzed using either a one-way or two-way analysis of variance (ANOVA) and, when appropriate, were followed by posttests. Error probabilities with P values of <0.05 were considered statistically significant.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
|
Mild hippocampus-dependent memory impairments in mouse models of CGD. It previously was shown that superoxide is required for hippocampus-dependent learning and memory (52, 53). Therefore, we determined whether NADPH oxidase is required for hippocampus-dependent memory by examining the gp91phox and the p47phox KO mice. Specifically, we examined the performance of these mice on two hippocampus-dependent learning and memory tasks: context-dependent conditioned fear and the MWM.
We first tested the p47phox and gp91phox KO mice for memory performance using a conditioned fear paradigm. In this task, the mice learn to fear a new context or an emotionally neutral conditioned stimulus (a tone) because of its association with an aversive unconditioned stimulus (a foot shock). When later exposed to either the same context (hippocampus and amygdala dependent) or the tone (amygdala dependent), the mice freeze, which is the stereotypical fear response used as an index of their memory (11, 39). In a two-trial learning paradigm, the gp91phox KO mice did not show any significant differences from their wild-type littermates in either contextual memory or cued memory (Fig. 8A). We also tested the gp91phox KO mice with a more difficult test for conditioned fear that involved only one training trial; however, these mice still did not exhibit any differences in freezing behavior compared to their wild-type littermates (data not shown). In contrast, the p47phox KO mice froze significantly less than their wild-type littermates when tested for contextual memory 24 h after training, but they performed similarly to wild-type littermates when tested for cued memory (Fig. 8B). These data are consistent with p47phox being required for the full expression of hippocampus-dependent contextual fear memory, though the effect of losing NADPH oxidase function through the loss of the p47phox subunit appears to be modest. We also tested the gp91phox KO and p47phox KO mice for performance in the MWM in order to assess hippocampus-dependent spatial learning and memory. In this task, the mice must learn and remember the relationship between distal cues and the location of a hidden platform in a pool of water (35). Compared to wild-type littermates, both the gp91phox KO and p47phox KO mice displayed small but significant deficits in their ability to find the platform during early training trials, which improved by the end of the 10-day experiment (Fig. 9A and E). Neither mutant line showed any differences in distance traveled or swim speed throughout the experiment (data not shown). These results are consistent with the interpretation that both lines of NADPH oxidase mutant mice exhibit mild spatial learning impairments.
|
|
OFA in mouse models of CGD. Deficits in the conditioned fear paradigm or the MWM could be caused by differences in exploratory behavior between mutant and wild-type mice. To address this possibility, we assessed the behavior of the gp91phox and p47phox KO mice in the open-field analysis (OFA) paradigm. An OFA tests mice for general exploratory behavior in a novel environment. gp91phox KO mice performed similarly to wild-type mice in both total distance traveled (Fig. 10A) and time spent in the center area relative to the total distance traveled (Fig. 10B), but they reared significantly less than their wild-type littermates (Fig. 10C). These results suggest that gp91phox KO mice for the most part exhibit normal exploratory behavior. Analysis of the p47phox KO mice revealed that these mice performed similarly to their wild-type littermates in total distance traveled (Fig. 10D) and rearing activity (Fig. 10F), but they spent slightly increased time in the center of the arena relative to the total distance traveled (Fig. 10E). Taken together, these results suggest that both mouse models of CGD exhibit largely normal exploratory behavior.
|
|
| DISCUSSION |
|---|
|
|
|---|
Previous studies have shown that superoxide is required for NMDA receptor-dependent LTP (25, 26, 53). Furthermore, NMDA receptor-dependent signaling in the hippocampus, in particular activation of protein kinase C and ERK, requires superoxide (24, 26) and, in the case of ERK activation, a functional NADPH oxidase complex (24). All together, these findings suggest that NAPDH oxidase is an important source of superoxide that is required for activation of signaling cascades that underlie hippocampal LTP.
The source(s) of superoxide required for NMDA receptor-dependent synaptic plasticity in the hippocampus is an open question. Activation of the NMDA receptor results in the production of superoxide (10, 15, 44). In addition to NADPH oxidase, several other sources of superoxide have been implicated previously in LTP, including mitochondria, nitric oxide synthase (NOS), and arachidonic acid. For example, NMDA receptor activation in hippocampal slices has been shown to result in increased production of superoxide via the mitochondrial electron transport chain (4). In addition, in cultured hippocampal neurons mitochondria have been implicated as a source of superoxide that is necessary for activity-dependent increases in the phosphorylation of cyclic AMP response element binding protein (18), a transcription factor known to be a downstream effector of ERK, both of which are important signaling molecules involved in LTP (50). Also, NOS activity has been shown to be necessary for LTP induction and under certain conditions can generate superoxide that can be blocked by NOS inhibitors (17, 41, 42). Arachidonic acid has also been shown to be a critical messenger molecule during LTP (32), and its metabolism may produce superoxide that is dependent on glutamate receptor stimulation (8, 44) and is required for the induction of LTP (55-57). Finally, NADPH oxidase has been shown to produce large, localized quantities of superoxide (43). The regulation and expression pattern of NADPH oxidase strongly suggest that it could be an important source of superoxide in LTP.
The results presented in this study are the first to directly demonstrate that NADPH oxidase subunits p47phox and gp91phox are necessary for E-LTP (Fig. 1 and 2). Interestingly, previous studies have shown that superoxide was not required for LTP that was induced using multiple trains of HFS; thus, by using a more robust LTP induction protocol, the requirement of superoxide could be overcome. Consistent with this idea, we found that L-LTP was intact in gp91phox KO mice (Fig. 3A) and slightly enhanced in the p47phox KO mice (Fig. 3B) compared to wild-type littermates. Our results provide further evidence that superoxide plays differential roles in E-LTP and L-LTP, with superoxide being required only for E-LTP.
Previous experiments with superoxide-scavenging compounds have shown that there is an immediate decrease in E-LTP following HFS (25, 53). We observed a similar phenomenon in E-LTP experiments in hippocampal slices from p47phox and gp91phox KO mice (Fig. 1 and 2). In addition, we found that the gp91phox KO mice displayed a profound deficit in PTP (Fig. 7A) that was mimicked by the application of DPI, which inhibits the function of gp91phox to wild-type slices (Fig. 7B). These findings indicate that the inhibition of the gp91phox subunit of NADPH oxidase results in not only E-LTP deficits but also impaired PTP. Interestingly, the deficit in PTP was not observed in slices from the p47phox KO mice (Fig. 7A), which together with the enhancement in the L-LTP phenotype (Fig. 3) suggests the possibility that gp91phox contributes to hippocampal synaptic plasticity independent of p47phox.
LTP is a physiological phenomenon that models processes thought to underlie memory formation. Many of the molecules that are required for LTP are also required for memory formation, including superoxide. Superoxide has been strongly implicated in hippocampus-dependent memory formation (13, 28, 47, 52, 53). Specifically, mice that overexpress extracellular superoxide dismutase (EC-SOD) show impaired context-dependent fear memory (52, 53) as well as impairments measured in the eight-arm radial maze (28), two assays for hippocampus-dependent memory. Also, mice that overexpress SOD-1 exhibit impaired performance in the MWM (13). Consistent with NADPH oxidase being a required source of superoxide during memory formation, p47phox KO mice showed deficits in contextual fear memory (Fig. 8B); however, gp91phox KO mice showed no deficits in this type of memory (Fig. 8A). On the other hand, gp91phox KO mice showed a mild deficit in spatial memory in the MWM that was overcome with more training (Fig. 9D), whereas both the gp91phox and the p47phox KO mice only exhibited deficits in the latency times during training (Fig. 9A and E). Taken together, these results suggest that gp91phox and p47phox may function independently of one another in certain types of hippocampus-dependent memory.
Compared to previous studies with EC-SOD-overexpressing mice (53), the memory deficits in the NADPH oxidase mutant mice observed are relatively mild. Interestingly, the effects of EC-SOD overexpression on learning seem to have a motivational component (29). At low motivational levels the EC-SOD-overexpressing mice perform the radial arm task poorly, whereas when motivated, they perform the task equal to wild-type mice (29). Because motivation was not examined in the experiments performed here with the NADPH oxidase mutant mice, we cannot rule out the possibility that alterations in motivation are responsible for the memory impairments we have observed.
Both contextual fear and spatial memory require the hippocampus; however, the hippocampus is not sufficient for these behaviors (39). Other brain structures are involved in contextual and spatial memory, and these structures may require p47phox and gp91phox and/or their respective homologues. We obtained evidence that NADPH oxidase is required for behaviors that are hippocampus independent. For example, proper performance on the rotating rod has been shown to require the cerebellar cortex and deep cerebellar nuclei for motor learning and coordination (5). We observed slight differences between the gp91phox KO mice and their littermates in their performance on the rotating rod (Fig. 11A) that may reflect altered function in either the cerebellar cortex or the deep cerebellar nuclei in the mutants. These results suggest that NADPH oxidase may play an important role in synaptic plasticity and function in extrahippocampal areas.
Interestingly, there seems to be a delicate balance of reactive oxygen species (ROS) levels that are required for signaling, whereas too little or too much ROS can result in impairments in LTP and memory (23, 27). Consistent with this hypothesis, there seems to be an age-related shift in the role of ROS signaling in hippocampal LTP and memory formation (19, 23, 27, 30). For instance, in young mice that overexpress SOD-1, LTP is impaired, but this impairment can be rescued with the application of hydrogen peroxide (23). Interestingly, as these mice age, they show an enhancement of LTP that is inhibited by application of H2O2 (23), whereas application of H2O2 to aged wild-type slices rescues the age-related decline in LTP compared to younger mice (23). EC-SOD transgenic mice also show a similar deficit in LTP at young ages that switches to an enhancement of LTP at older ages (19). Furthermore, chronic treatment of mice with SOD mimetics or catalase mimetics reverses hippocampus-dependent learning deficits in aged mice (30). Thus, the role for ROS in hippocampal plasticity and memory during aging is complex. It will be important for future studies to elucidate the mechanisms underlying the changes in ROS involvement, including the potential changes that are associated with the source and regulation of ROS production during the aging process.
In this study, we have shown for the first time that mouse models of CGD display deficits in synaptic plasticity and mild impairments in cognitive function. CGD has an incidence of between 1:200,000 and 1:250,000 people (58), and identifying the cause of any potential cognitive abnormalities arising in these patients is important for understanding the molecular mechanisms underlying cognition. Preliminary findings suggest that there may be mild cognitive deficits in patients with CGD (37), consistent with the phenotypes we have observed in the CGD mouse models. Interestingly, there are a number of immunodeficiencies in which patients display cognitive and behavioral abnormalities (37). Many of the molecules implicated as the cause in these immunological diseases are expressed in the nervous system and thus may play a direct role in cognitive function that previously has not been addressed. Identifying the role these molecules play in synaptic plasticity and memory formation will be crucial to our understanding of the molecular mechanisms of cognition.
. . . . . .
| ACKNOWLEDGMENTS |
|---|
This work was supported by the National Institutes of Health intramural program of the National Institute of Allergy and Infectious Diseases (S.M.H.) and National Institutes of Health grants NS034007 (E.K.), NS047384 (E.K.), and NS047852 (K.T.K.).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Babior, B. M., J. D. Lambeth, and W. Nauseef. 2002. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397:342-344.[CrossRef][Medline]
3. Banko, J. L., F. Poulin, L. Hou, C. T. DeMaria, N. Sonenberg, and E. Klann. 2005. The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J. Neurosci. 25:9581-9590.
4. Bindokas, V. P., J. Jordan, C. C. Lee, and R. J. Miller. 1996. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16:1324-1336.
5. Caston, J., F. Vasseur, T. Stelz, C. Chianale, N. Delhaye-Bouchaud, and J. Mariani. 1995. Differential roles of cerebellar cortex and deep cerebellar nuclei in the learning of the equilibrium behavior: studies in intact and cerebellectomized lurcher mutant mice. Brain Res. Dev. Brain Res. 86:311-316.[Medline]
6. Clark, S. R., M. J. Coffey, R. M. Maclean, P. W. Collins, M. J. Lewis, A. R. Cross, and V. B. O'Donnell. 2002. Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and myeloperoxidase-deficient human neutrophils. J. Immunol. 169:5889-5896.
7. Cross, A. R., and A. W. Segal. 2004. The NADPH oxidase of professional phagocytesprototype of the NOX electron transport chain systems. Biochim. Biophys. Acta 1657:1-22.[Medline]
8. Culcasi, M., M. Lafon-Cazal, S. Pietri, and J. Bockaert. 1994. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J. Biol. Chem. 269:12589-12593.
9. Dringen, R. 2005. Oxidative and antioxidative potential of brain microglial cells. Antioxid. Redox Signal. 7:1223-1233.[CrossRef][Medline]
10. Dugan, L. L., S. L. Sensi, L. M. Canzoniero, S. D. Handran, S. M. Rothman, T. S. Lin, M. P. Goldberg, and D. W. Choi. 1995. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15:6377-6388.
11. Fanselow, M. S. 1984. Shock-induced analgesia on the formalin test: effects of shock severity, naloxone, hypophysectomy, and associative variables. Behav. Neurosci. 98:79-95.[CrossRef][Medline]
12. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, and K. Struhl (ed.). 2002. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
13. Gahtan, E., J. M. Auerbach, Y. Groner, and M. Segal. 1998. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur. J. Neurosci. 10:538-544.[CrossRef][Medline]
14. Groemping, Y., and K. Rittinger. 2005. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem. J. 386:401-416.[CrossRef][Medline]
15. Gunasekar, P. G., A. G. Kanthasamy, J. L. Borowitz, and G. E. Isom. 1995. NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J. Neurochem. 65:2016-2021.[Medline]
16. Hancock, J. T., and O. T. Jones. 1987. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem. J. 242:103-107.[Medline]
17. Heinzel, B., M. John, P. Klatt, E. Bohme, and B. Mayer. 1992. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 281:627-630.[Medline]
18. Hongpaisan, J., C. A. Winters, and S. B. Andrews. 2003. Calcium-dependent mitochondrial superoxide modulates nuclear CREB phosphorylation in hippocampal neurons. Mol. Cell Neurosci. 24:1103-1115.[CrossRef][Medline]
19. Hu, D., F. Serrano, T. D. Oury, and E. Klann. 2006. Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 26:3933-3941.
20. Hwang, J., A. Saha, Y. C. Boo, G. P. Sorescu, J. S. McNally, S. M. Holland, S. Dikalov, D. P. Giddens, K. K. Griendling, D. G. Harrison, and H. Jo. 2003. Oscillatory shear stress stimulates endothelial production of O2 from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J. Biol. Chem. 278:47291-47298.
21. Jackson, S. H., S. Devadas, J. Kwon, L. A. Pinto, and M. S. Williams. 2004. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5:818-827.[CrossRef][Medline]
22. Jackson, S. H., J. I. Gallin, and S. M. Holland. 1995. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182:751-758.
23. Kamsler, A., and M. Segal. 2004. Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol. Neurobiol. 29:167-178.[CrossRef][Medline]
24. Kishida, K. T., M. Pao, S. M. Holland, and E. Klann. 2005. NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J. Neurochem. 94:299-306.[CrossRef][Medline]
25. Klann, E. 1998. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J. Neurophysiol. 80:452-457.
26. Klann, E., E. D. Roberson, L. T. Knapp, and J. D. Sweatt. 1998. A role for superoxide in protein kinase C activation and induction of long-term potentiation. J. Biol. Chem. 273:4516-4522.
27. Knapp, L. T., and E. Klann. 2002. Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory? J. Neurosci. Res. 70:1-7.[CrossRef][Medline]
28. Levin, E. D., T. C. Brady, E. C. Hochrein, T. D. Oury, L. M. Jonsson, S. L. Marklund, and J. D. Crapo. 1998. Molecular manipulations of extracellular superoxide dismutase: functional importance for learning. Behav. Genet. 28:381-390.[CrossRef][Medline]
29. Levin, E. D., F. H. Brucato, and J. D. Crapo. 2000. Molecular overexpression of extracellular superoxide dismutase increases the dependency of learning and memory performance on motivational state. Behav. Genet. 30:95-100.[CrossRef][Medline]
30. Liu, R., I. Y. Liu, X. Bi, R. F. Thompson, S. R. Doctrow, B. Malfroy, and M. Baudry. 2003. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. USA 100:8526-8531.
31. Lomax, K. J., T. L. Leto, H. Nunoi, J. I. Gallin, and H. L. Malech. 1989. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245:409-412.
32. Lynch, M. A., M. L. Errington, and T. V. Bliss. 1989. Nordihydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increases in release of glutamate and arachidonate: an in vivo study in the dentate gyrus of the rat. Neuroscience 30:693-701.[CrossRef][Medline]
33. Mohd Noh, L., R. M. Noah, L. L. Wu, B. A. Nasuruddin, E. Junaidah, C. P. Ooi, and I. Rose. 1994. Chronic granulomatous diseasea report in two Malay families. Singapore Med. J. 35:505-508.[Medline]
34. Morgenstern, D. E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185:207-218.
35. Morris, R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11:47-60.[CrossRef][Medline]
36. Nauseef, W. M. 2004. Assembly of the phagocyte NADPH oxidase. Histochem. Cell Biol. 122:277-291.[CrossRef][Medline]
37. Pao, M., E. A. Wiggs, M. M. Anastacio, J. Hyun, E. S. DeCarlo, J. T. Miller, V. L. Anderson, H. L. Malech, J. I. Gallin, and S. M. Holland. 2004. Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics 45:230-234.
38. Paylor, R., M. Nguyen, J. N. Crawley, J. Patrick, A. Beaudet, and A. Orr-Urtreger. 1998.
7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of acra7-deficient mice. Learning Memory 5:302-316.
39. Phillips, R. G., and J. E. LeDoux. 1995. Lesions of the fornix but not the entorhinal or perirhinal cortex interfere with contextual fear conditioning. J. Neurosci. 15:5308-5315.[Abstract]
40. Pollock, J. D., D. A. Williams, M. A. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.[CrossRef][Medline]
41. Pou, S., L. Keaton, W. Surichamorn, and G. M. Rosen. 1999. Mechanism of superoxide generation by neuronal nitric-oxide synthase. J. Biol. Chem. 274:9573-9580.
42. Pou, S., W. S. Pou, D. S. Bredt, S. H. Snyder, and G. M. Rosen. 1992. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267:24173-24176.
43. Quinn, M. T., and K. A. Gauss. 2004. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J. Leukoc. Biol. 76:760-781.
44. Reynolds, I. J., and T. G. Hastings. 1995. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15:3318-3327.[Abstract]
45. Royer-Pokora, B. 1987. Novel approaches for cloning human genes: the chronic granulomatous disease (CGD). Dis. Markers 5:57-58.[Medline]
46. Serrano, F., N. S. Kolluri, F. B. Wientjes, J. P. Card, and E. Klann. 2003. NADPH oxidase immunoreactivity in the mouse brain. Brain. Res. 988:193-198.[CrossRef][Medline]
47. Spalloni, A., R. Geracitano, N. Berretta, C. Sgobio, G. Bernardi, N. B. Mercuri, P. Longone, and M. Ammassari-Teule. 2006. Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly(93)
ALA) mutation. Exp. Neurol. 197:505-514.[CrossRef][Medline]
48. Stolk, J., P. Davies, J. A. Kramps, J. H. Dijkman, J. J. Humes, W. B. Knight, B. G. Green, R. Mumford, R. J. Bonney, and W. A. Hanlon. 1992. Potency of antileukoprotease and alpha 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease. Am. J. Respir. Cell Mol. Biol. 6:521-526.[Medline]
49. Sumimoto, H., N. Ueno, T. Yamasaki, M. Taura, and R. Takeya. 2004. Molecular mechanism underlying activation of superoxide-producing NADPH oxidases: roles for their regulatory proteins. Jpn. J. Infect. Dis. 57:S24-S25.[Medline]
50. Sweatt, J. D. 2001. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76:1-10.[CrossRef][Medline]
51. Tejada-Simon, M., F. Serrano, L. E. Villasana, B. I. Kanterewicz, G. Y. Wu, M. T. Quinn, and E. Klann. 2005. Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol. Cell. Neurosci. 29:97-106.[CrossRef][Medline]
52. Thiels, E., and E. Klann. 2002. Hippocampal memory and plasticity in superoxide dismutase mutant mice. Physiol. Behav. 77:601-605.[CrossRef][Medline]
53. Thiels, E., N. N. Urban, G. R. Gonzalez-Burgos, B. I. Kanterewicz, G. Barrionuevo, C. T. Chu, T. D. Oury, and E. Klann. 2000. Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 20:7631-7639.
54. Vallet, P., Y. Charnay, K. Steger, E. Ogier-Denis, E. Kovari, F. Herrmann, J. P. Michel, and I. Szanto. 2005. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132:233-238.[CrossRef][Medline]
55. Watson, J. B., H. Khorasani, A. Persson, K. P. Huang, F. L. Huang, and T. J. O'Dell. 2002. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. J. Neurosci. Res.